• Profile
Close

Efficacy of Indigo naturalis in a multicenter randomized controlled trial of patients with ulcerative colitis

Gastroenterology Nov 30, 2017

Naganuma M, et al. - The safety and efficacy of Indigo naturalis (IN) were examined in patients with ulcerative colitis (UC). The researchers found 8 weeks of IN (0.5–2.0 g per day) to be effective in inducing a clinical response among patients with UC in a randomized, placebo-controlled trial. IN, however, was not recommended yet due to the potential for adverse effects, including pulmonary arterial hypertension.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay